Surface immunoglobulin‐positive lymphoblastic lymphoma a report of three cases

Lymphoblastic lymphomas (LBL) are a morphologically homogeneous group of non‐Hodgkin's lymphomas which are indistinguishable in tissue sections from acute lymphoblastic leukemia (ALL). Although initial immunologic studies of LBL suggested that these lymphomas are of the T‐cell phenotype, investigations have recently described patients with LBL having pre‐B‐cell, “common” ALL, and natural killer cell phenotypes. The authors recently reported detailed immunophenotypic characteristics in 36 cases of LBL, including a single case of LBL with a surface immunoglobulin‐positive B‐cell phenotype. Three additional patients with LBL whose cells expressed monoclonal serum immunoglobulins are presented here. In addition, the neoplastic lymphocytes expressed several B‐cell‐associated antigens. The tumor cells in the single case tested were TdT‐negative. Despite the unusual immunologic phenotype, the morphologic features in all three cases were characteristic of LBL. In addition to the previously reported single case, to the authors' knowledge these are the only reported cases of a previously unrecognized variant of LBL: surface immunoglobulin‐positive, B‐cell LBL.

[1]  L. R. Hill,et al.  Antigenically defined subgroups of lymphoblastic lymphoma. Relationship to clinical presentation and biologic behavior , 1987, Cancer.

[2]  R. Warnke,et al.  Lymphoblastic lymphoma: an immunophenotype study of 26 cases with comparison to T cell acute lymphoblastic leukemia. , 1986, Blood.

[3]  B. Nathwani,et al.  Small lymphocytic lymphoma. Morphologic and immunologic progression. , 1985, American journal of clinical pathology.

[4]  Tak W. Mak,et al.  A human T cell-specific cDNA clone encodes a protein having extensive homology to immunoglobulin chains , 1984, Nature.

[5]  R. Fisher,et al.  Diversity of immunological phenotypes of lymphoblastic lymphoma. , 1983, Cancer research.

[6]  M. Link,et al.  Cutaneous lymphoblastic lymphoma with pre-B markers. , 1983, Blood.

[7]  M. Cooper,et al.  Monoclonal antibody characterization of surface antigens in childhood T-cell lymphoid malignancies. , 1983, Blood.

[8]  James R. Anderson,et al.  Childhood non-Hodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2). , 1983, The New England journal of medicine.

[9]  B. Croker,et al.  Lymphoblastic lymphoma with the phenotype of common acute lymphoblastic leukemia. , 1983, American journal of clinical pathology.

[10]  T. Lebien,et al.  CLINICAL USEFULNESS OF MONOCLONAL- ANTIBODY PHENOTYPING IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKAEMIA , 1982, The Lancet.

[11]  J. Rowley,et al.  Lymphoblastic lymphoma: Cytogenetic, pathologic, and immunologic studies , 1982, International journal of cancer.

[12]  J. Maizel,et al.  Evolution of human immunoglobulin kappa J region genes. , 1982, The Journal of biological chemistry.

[13]  T. Waldmann,et al.  Clustered arrangement of immunoglobulin λ constant region genes in man , 1981, Nature.

[14]  Ulrich Siebenlist,et al.  Structure of the human immunoglobulin μ locus: Characterization of embryonic and rearranged J and D genes , 1981, Cell.

[15]  B. Nathwani,et al.  Lymphoblastic lymphoma: A clinicopathologic study of 95 patients , 1981, Cancer.

[16]  J. Dausset,et al.  Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lymphoblastic lymphoma , 1981 .

[17]  E. Reinherz,et al.  Discrete stages of human intrathymic differentiation: analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineage. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Lukes Rj The immunologic approach to the pathology of malignant lymphomas. , 1979 .

[19]  J. Parker,et al.  Convoluted lymphocytic lymphoma in adults: a clinicopathologic entity. , 1978, Annals of internal medicine.

[20]  E. Jaffe,et al.  Lymphoblastic lymphoma, a term rekindled with new precision. , 1978, Annals of internal medicine.

[21]  B N Nathwani,et al.  Malignant lymphoma, lymphoblastic , 1976, Cancer.

[22]  R. Lukes,et al.  Immunologic characterization of human malignant lymphomas , 1974, Cancer.

[23]  B. Nathwani,et al.  Lymphoblastic lymphoma expressing natural killer cell-associated antigens: a clinicopathologic study of six cases. , 1987, Leukemia research.

[24]  S. Swerdlow,et al.  T lymphoblastic lymphoma with LEU-7 positive phenotype and unusual clinical course: a multiparameter study. , 1985, Leukemia research.

[25]  E. Jaffe,et al.  Predictability of immunologic phenotype by morphologic criteria in diffuse aggressive non-Hodgkin's lymphomas. , 1982, American journal of clinical pathology.

[26]  P. Hedqvist,et al.  ヒトにおけるアレルゲン誘発ぜん息後の15‐ケト‐13,14‐ジヒドロ‐プロスタグランジンF2αの血しょう値上昇 , 1974 .